Abiopharma

Clinical trial NCT05319730: enrollment: not set → 230 participants.

Presentation to the capital market May 2026

Engagement in a conditional framework of agreements for the purchase of about 19% of the capital of Radler Ltd. for approximately US$2.9 million, details, continuation

Trident Resources Intersects Additional High-Grade Gold at Contact Lake Grading 17.88 g/t Au over 11.25m, including 42.53 g/t over 4.50m from 86m Depth

The company’s outstanding liabilities as of 31.3.26, by maturity dates

Q1 2026 report

Change in holdings of interested parties/officers

Zealand Pharma to Present Data at the American Diabetes Associations 2026 Scientific Sessions

Investor presentation Q1 2026

S&P Maalot rating ‘ilA-1’ for the issuance of commercial papers 6 in a scope of up to NIS 450 million par value